The cancer drug price cap India announced this month is now official. The National Pharmaceutical Pricing Authority (NPPA) has capped trade margins on 137 non-scheduled anti-cancer drugs at 30% of the maximum retail price (MRP). The revised prices are due to apply from November 9, 2026. Cancer treatment can be a heavy financial burden for families, and many newer medicines are expensive. Here is a clear explanation of what the cap means, which medicines are covered, and how patients and caregivers can check the new prices. Cancer Drug Price Cap…
Read More